130 related articles for article (PubMed ID: 7816875)
1. Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 2. 2-deoxy-D-glucose.
Schaefer LA; Koch JE; Bodnar RJ
Pharmacol Biochem Behav; 1994 Sep; 49(1):205-11. PubMed ID: 7816875
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone, dopamine receptor agonists and antagonists, and food intake in rats: 1. Food deprivation.
Hobbs DJ; Koch JE; Bodnar RJ
Pharmacol Biochem Behav; 1994 Sep; 49(1):197-204. PubMed ID: 7816874
[TBL] [Abstract][Full Text] [Related]
3. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
Mittleman G; Rosner AL; Schaub CL
J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
[TBL] [Abstract][Full Text] [Related]
4. Activation of D1, but not D2 receptors potentiates dizocilpine-mediated disruption of prepulse inhibition of the startle.
Bortolato M; Aru GN; Fà M; Frau R; Orrù M; Salis P; Casti A; Luckey GC; Mereu G; Gessa GL
Neuropsychopharmacology; 2005 Mar; 30(3):561-74. PubMed ID: 15328529
[TBL] [Abstract][Full Text] [Related]
5. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
LaHoste GJ; Marshall JF
Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
[TBL] [Abstract][Full Text] [Related]
6. Effects of selective dopamine receptor compounds on single, spontaneously-active neostriatal neurons.
Nantwi KD; Schoener EP
Gen Pharmacol; 1994 Nov; 25(7):1439-43. PubMed ID: 7896058
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
8. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
Byrnes EM; Bruno JP
Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
[TBL] [Abstract][Full Text] [Related]
9. Do D1/D2 interactions regulate prepulse inhibition in rats?
Wan FJ; Taaid N; Swerdlow NR
Neuropsychopharmacology; 1996 Apr; 14(4):265-74. PubMed ID: 8924194
[TBL] [Abstract][Full Text] [Related]
10. Behavioral effects of dopaminergic agonists and antagonists alone and in combination in the squirrel monkey.
Katz JL; Witkin JM
Psychopharmacology (Berl); 1993; 113(1):19-25. PubMed ID: 7862823
[TBL] [Abstract][Full Text] [Related]
11. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
[TBL] [Abstract][Full Text] [Related]
12. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of D2 receptor agonist-induced inhibition by D1 receptor agonist in the ventral tegmental area.
Momiyama T; Sasa M; Takaori S
Br J Pharmacol; 1993 Oct; 110(2):713-8. PubMed ID: 7902179
[TBL] [Abstract][Full Text] [Related]
14. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
Weick BG; Walters JR
Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
[TBL] [Abstract][Full Text] [Related]
15. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
Engber TM; Marin C; Susel Z; Chase TN
Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
[TBL] [Abstract][Full Text] [Related]
17. Drug discrimination in methamphetamine-trained monkeys: agonist and antagonist effects of dopaminergic drugs.
Tidey JW; Bergman J
J Pharmacol Exp Ther; 1998 Jun; 285(3):1163-74. PubMed ID: 9618419
[TBL] [Abstract][Full Text] [Related]
18. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
Koshikawa N; Kitamura M; Kobayashi M; Cools AR
Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
[TBL] [Abstract][Full Text] [Related]
19. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
[TBL] [Abstract][Full Text] [Related]
20. Role of dopamine D1 and D2 receptors in the micturition reflex in conscious rats.
Seki S; Igawa Y; Kaidoh K; Ishizuka O; Nishizawa O; Andersson KE
Neurourol Urodyn; 2001; 20(1):105-13. PubMed ID: 11135387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]